Showing results (1051-1060 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|June 14, 2018
An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer PerspectiveLindsay Claxton, Matthew Taylor, Arif Soonasra, et al.Journal of Managed Care & Specialty Pharmacy|July 21, 2018
Health Care Utilization and Expenditures Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the United StatesTheodore K Marras, Mehdi Mirsaeidi, Engels Chou, et al.Journal of Managed Care & Specialty Pharmacy|May 24, 2017
Why Value Framework Assessments Arrive at Different Conclusions: A Multiple Myeloma Case StudyKimberly Westrich, Lisabeth Buelt, Robert W DuboisJournal of Managed Care & Specialty Pharmacy|May 24, 2017
Measuring the Value of New Drugs: Validity and Reliability of 4 Value Assessment Frameworks in the Oncology SettingTanya G K Bentley, Joshua T Cohen, Elena B Elkin, et al.Journal of Managed Care & Specialty Pharmacy|May 23, 2017
Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?Jason T Hurwitz, Mary Brown, Jennifer S Graff, et al.Journal of Managed Care & Specialty Pharmacy|May 23, 2017
Health Care Costs Associated with Addition, Titration, and Switching Antihypertensive Medications After First-Line Treatment: Results from a Commercially Insured SampleKalyani B Sonawane Deshmukh, Jingjing Qian, Kimberly B Garza, et al.Journal of Managed Care & Specialty Pharmacy|April 28, 2017
The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid PopulationStephanie Tran, Pavel Lavitas, Karen Stevens, et al.Journal of Managed Care & Specialty Pharmacy|April 28, 2017
Economic Impact of Above-Label Dosing with Etanercept, Adalimumab, or Ustekinumab in Patients with PsoriasisSteven R Feldman, Yang Zhao, Huanxue Zhou, et al.Journal of Managed Care & Specialty Pharmacy|April 28, 2017
AMCP Partnership Forum: Driving Value and Outcomes in OncologyJournal of Managed Care & Specialty Pharmacy|April 26, 2018
Letter--Use of Objectives in Research ArticlesRichard L Ogletree, Kayla Peeler Douglas, Lillie Floyd, et al.Pageof 185